A paradigm shift in platelet transfusion therapy

Abstract

In this issue of Blood, Wang et al report that ex vivo-derived human megakaryocytes infused into mice are trapped in the pulmonary vasculature and release functional platelets into the circulation. Because of the difficulty in scalable generation of ex vivo-derived functional platelets, this strategy may be a substitute for platelet transfusion therapy.